---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-207814"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2024-08-27T23:59:59+00:00"
generated_at: "2026-05-31T07:24:51.484531+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Verrica CCO Joe Bonaccorso resigns effective Aug 30, 2024; consulting role through Aug 2025

## Summary
- Joe Bonaccorso resigns as Chief Commercial Officer effective August 30, 2024.
- Separation benefits include 12 months base salary and up to 12 months COBRA coverage.
- Consulting Agreement runs through August 30, 2025, with no cash compensation; outstanding equity continues vesting.
- Company expects to enter into Release and Consulting Agreements with Bonaccorso.

## SEC filing metadata
- accession: 0001193125-24-207814
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2024-08-27T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312524207814/0001193125-24-207814-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312524207814/d890208d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-207814
- JSON: https://secwatch.observer/filing/0001193125-24-207814.json
- Plain text: https://secwatch.observer/filing/0001193125-24-207814.txt

## Key facts
- Executive change
  Joe Bonaccorso resigned as Chief Commercial Officer at Verrica Pharmaceuticals Inc..
  - Action: resigned
  - Role: Chief Commercial Officer
  source text: On August 21, 2024, Mr. Bonaccorso notified Verrica Pharmaceuticals Inc. (the “Company”) that he will resign from his position as Chief Commercial Officer of the Company, effective August 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1660334/000119312524207814/0001193125-24-207814-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.